Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.
暂无分享,去创建一个
A Ammassari | A. De Luca | A. Cingolani | S. Di Giambenedetto | F. Baldini | R. Murri | A. Ammassari | R Murri | F Baldini | S Di Giambenedetto | A Cingolani | A De Luca
[1] M. Linton,et al. Current perspectives on statins. , 2000, Circulation.
[2] J. Murillas,et al. Atorvastatin for protease inhibitor-related hyperlipidaemia. , 1999, AIDS.
[3] M. Shelton,et al. Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients. , 1999, AIDS.
[4] A. Maestre,et al. Acute Pancreatitis as a Complication of Ritonavir Therapy in a Patient with AIDS , 1998, European Journal of Clinical Microbiology and Infectious Diseases.
[5] U. Eriksson,et al. Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients? , 1998, AIDS.
[6] K. Henry,et al. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities , 1998, The Lancet.
[7] D. Vittecoq,et al. Vascular complications associated with use of HIV protease inhibitors , 1998, The Lancet.
[8] David A. Cooper,et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors , 1998, AIDS.